Quantbot Technologies LP decreased its position in The Clorox Company (NYSE:CLX - Free Report) by 98.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 272 shares of the company's stock after selling 13,188 shares during the quarter. Quantbot Technologies LP's holdings in Clorox were worth $44,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in CLX. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter worth approximately $27,000. Innealta Capital LLC acquired a new stake in Clorox during the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC grew its position in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after buying an additional 130 shares in the last quarter. Family Firm Inc. acquired a new stake in Clorox during the second quarter worth approximately $31,000. Finally, Quarry LP grew its position in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after buying an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.
Analyst Upgrades and Downgrades
CLX has been the topic of a number of analyst reports. JPMorgan Chase & Co. increased their price target on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research report on Friday, October 11th. DA Davidson raised their target price on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a report on Monday, November 4th. BNP Paribas raised Clorox to a "strong sell" rating in a report on Friday, September 6th. Jefferies Financial Group raised Clorox from a "hold" rating to a "buy" rating and raised their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, Barclays raised their target price on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a report on Friday, November 1st. Five investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $155.00.
Get Our Latest Analysis on CLX
Clorox Price Performance
Shares of CLX traded down $2.77 during trading hours on Friday, reaching $166.97. The stock had a trading volume of 1,217,064 shares, compared to its average volume of 1,054,507. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a market capitalization of $20.67 billion, a PE ratio of 58.18, a PEG ratio of 3.10 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company's 50-day moving average is $163.50 and its two-hundred day moving average is $150.49.
Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. During the same period in the prior year, the company earned $0.49 EPS. Clorox's revenue was up 27.0% compared to the same quarter last year. Research analysts expect that The Clorox Company will post 6.85 EPS for the current year.
Clorox Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.92%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's dividend payout ratio is currently 170.03%.
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.